Výsledky vyhledávání - Giuseppe Morelli

  • Zobrazuji výsledky 1 - 14 z 14
Upřesnit hledání
  1. 1
    Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease

    Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease Autor Fares Ayoub, Cesar Trillo‐Alvarez, Giuseppe Morelli, Jorge Lascano

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Neutrophil–lymphocyte ratio predicts overall and recurrence‐free survival after liver transplantation for hepatocellular carcinoma

    Neutrophil–lymphocyte ratio predicts overall and recurrence‐free survival after liver transplantation for hepatocellular carcinoma Autor Alpna R. Limaye, Virginia Clark, Consuelo Soldevila‐Pico, Giuseppe Morelli, Amitabh Suman, Roberto J. Firpi, David R. Nelson, Roniel Cabrera

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    The natural history of hepatitis C cirrhosis after liver transplantation

    The natural history of hepatitis C cirrhosis after liver transplantation Autor Roberto J. Firpi, Virginia Clark, Consuelo Soldevila‐Pico, Giuseppe Morelli, Roniel Cabrera, Cynthia Levy, Victor I. Machicao, Chaoru Chen, David R. Nelson

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

    Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results Autor Bruce R. Bacon, Mitchell L. Shiffman, Flavia Mendes, Reem Ghalib, Tarek Hassanein, Giuseppe Morelli, Shobha Joshi, Kenneth D. Rothstein, Paul Y. Kwo, Norman Gitlin

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma

    Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma Autor Renumathy Dhanasekaran, Alan W. Hemming, Ivan Zendejas, Thomas J. George, David R. Nelson, Consuelo Soldevila‐Pico, Roberto J. Firpi, Giuseppe Morelli, Virginia Clark, Roniel Cabrera

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation

    Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation Autor Roberto J. Firpi, Haizhen Zhu, Giuseppe Morelli, Manal F. Abdelmalek, Consuelo Soldevila‐Pico, Victor I. Machicao, Roniel Cabrera, Alan Reed, Chen Liu, David R. Nelson

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Sofosbuvir‐velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct‐acting antiviral regimen

    Sofosbuvir‐velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct‐acting antiviral regimen Autor Edward Gane, Mitchell L. Shiffman, K. Peter Etzkorn, Giuseppe Morelli, Catherine Stedman, Mitchell Davis, Federico Hinestrosa, Hadas Dvory‐Sobol, Kaijiao Huang, Anu Osinusi, John McNally, Diana M. Brainard, John G. McHutchison, A. Thompson, Mark Sulkowski

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo

    Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo Autor Catherine Frenette, Giuseppe Morelli, Mitchell L. Shiffman, R. Todd Frederick, Raymond A. Rubin, Michael B. Fallon, Jason T. Cheng, Matt Cave, Saira Khaderi, Omar Massoud, Nikolaos Pyrsopoulos, James Park, James M. Robinson, Mason Yamashita, Alfred P. Spada, Jean L. Chan, David Hagerty

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research network

    Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research network Autor Robert S. Brown, Jacqueline G. O’Leary, K. Rajender Reddy, Alexander Kuo, Giuseppe Morelli, James R. Burton, R. Todd Stravitz, Christine M. Durand, Adrian M. Di Bisceglie, Paul Y. Kwo, Catherine Frenette, Thomas G. Stewart, David R. Nelson, Michael Fried, Norah A. Terrault

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

    DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort Autor Elizabeth C. Verna, Giuseppe Morelli, Norah A. Terrault, Anna S. Lok, Joseph K. Lim, Adrian M. Di Bisceglie, Stefan Zeuzem, Charles Landis, Paul Y. Kwo, Mohamed A. Hassan, Michael P. Manns, Monika Vainorius, Lucy Akushevich, David R. Nelson, Michael Fried, K. Rajender Reddy

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study

    Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study Autor Tania M. Welzel, David R. Nelson, Giuseppe Morelli, Adrian M. Di Bisceglie, K. Rajender Reddy, Alexander Kuo, Joseph K. Lim, Jama M. Darling, Paul J. Pockros, Joseph Galati, Lynn M. Frazier, Saleh A. Alqahtani, Mark Sulkowski, Monika Vainorius, Lucy Akushevich, Michael Fried, Stefan Zeuzem

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

    Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy Autor Anna S. Lok, Mark Sulkowski, Jens Kort, Ira Willner, K. Rajender Reddy, Mitchell L. Shiffman, Mohamed A. Hassan, Brian L. Pearlman, Federico Hinestrosa, Ira M. Jacobson, Giuseppe Morelli, Joy Peter, Monika Vainorius, Larry C. Michael, Michael Fried, Gary P. Wang, Wenjing Lü, Lois Larsen, David R. Nelson

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations

    Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations Autor Zachary M. Sellers, David N. Assis, Shruti Paranjape, Meghana Sathe, Frank A.J.A. Bodewes, Melissa Bowen, Marco Cipolli, Dominique Debray, Nicole Green, Kara S. Hughan, William R. Hunt, Julio Leey, Simon C. Ling, Giuseppe Morelli, D. Peckham, Rebeca S. Pettit, Alexander H Philbrick, Janis Stoll, Kay Vavrina, Stacy Allen, T. Martin Goodwin, Sarah E. Hempstead, Michael R. Narkewicz

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

    Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection Autor Mark Sulkowski, Hugo E. Vargas, Adrian M. Di Bisceglie, Alexander Kuo, K. Rajender Reddy, Joseph K. Lim, Giuseppe Morelli, Jama M. Darling, Jordan J. Feld, Robert S. Brown, Lynn M. Frazier, Thomas G. Stewart, Michael Fried, David R. Nelson, Ira M. Jacobson, Nezam H. Afdhal, Ibrar Alam, Ziv Ben‐Ari, James E. Bredfeldt, Robert S. Brown, Ray Chung, Jama M. Darling, W. R. Harlan, Adrian M. Di Bisceglie, Rolland C. Dickson, Hany Elbeshbeshy, Gregory T. Everson, Jordan J. Feld, Jonathan M. Fenkel, Michael Fried, Joseph Galati, Stuart C. Gordon, Mohamed A. Hassan, Trevor Hawkins, Federico Hinestrosa, Ira M. Jacobson, C.A. Kerr, Alexander Kuo, Paul Y. Kwo, Josh Levitsky, Joseph K. Lim, Anna S. Lok, Mark E. Mailliard, Michael P. Manns, G. Morelli, Andrew J. Muir, David R. Nelson, Jacqueline G. O’Leary, Brian L. Pearlman, Paul J. Pockros, A Ramani, Nancy Reau, K. Rajender Reddy, E. Schiff, K.E. Sherman, Mitchell L. Shiffman, Catherine M. Smith, James R. Spivey, Richard K. Sterling, Mark Sulkowski, Greta Szabo, Norah A. Terrault, Christian Trautwein, Hugo E. Vargas, Kate Watts, Analee Williams, Stefan Zeuzem

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: